Home » Topics » BioWorld Science

BioWorld Science
RSS

Metabolic differences of ApoE variants

July 16, 2018

Cytokine gene therapy improves spinal cord regeneration

July 16, 2018

CARD-carrying AML killer

July 16, 2018

FDA approves Opdivo + Yervoy for MSI-H or dMMR metastatic colorectal cancer

July 13, 2018

Jiangsu Wanbang Biopharmaceutical cleared to begin clinical trials of SGLT2 inhibitor in China

July 13, 2018

Recruitment open for phase IIa study of Nerofe for AML and MDS

July 13, 2018

Roche presents phase II data for olesoxime in patients with SMA

July 13, 2018

Shenzhen Chipscreen Biosciences patents indoleamine 2,3-dioxygenase 1 inhibitors

July 13, 2018

Lilly presents IDH1 and IDH2 mutant inhibitors

July 13, 2018

N-Acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...